The Long, Winding Road of Immunotherapy Research
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
Tag: blood cancers
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
The FDA issued 14 oncology approvals this quarter, including the first tumor-infiltrating lymphocyte therapy.
Researchers at the Blood Cancer Discovery Symposium presented data on multidrug resistance and clinical trial design.
AACR will host the inaugural Blood Cancer Discovery Symposium March 4-6, 2024, featuring experts from all areas of blood...
Our immune systems are equipped to recognize and destroy cancer cells—if they can find them, that is. And with...
For our readers who enjoy learning about the newest tools and strategies in cancer research, the second installment of...
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
As the spring weather encourages the planting of flowers, vegetables, and herbs, even careful gardeners may see weeds creeping...
How the latest clinical therapies are helping patients and laboratory research informing future treatments.
The end of the year presents a unique opportunity to look back on recent accomplishments, take inventory of successes...